Clinical Implications of the Pharmacokinetics of Tricyclic Antidepressants
Knowledge gained during the past 20 years about the pharmacokinetics of tricyclic antidepressant drugs has helped to refine clinical practice. This discussion will focus on kinetic features of tricyclic antidepressants which appear to have important implications for clinical practice.
KeywordsPlacebo Toxicity Depression Noradrenaline Tricyclic
Unable to display preview. Download preview PDF.
- APA Task Force on the Use of Laboratory Tests in Psychiatry (1985) Tricyclic antidepressants - blood level measurements and clinical outcome: an APA task force report. Am J Psychiatry 142: 155–162Google Scholar
- Javaid JI, Matuzas W, Davis JM, Fawcett J (1985) Plasma protein binding of tricyclic antidepressants in young and elderly. Presented at the American College of Neuro-psychopharmacology, Annual Meeting, December 1985Google Scholar
- Kutcher SP, Shulman KI, Reed K (1986 b) Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study. Can J Psychiatry 31: 752–754Google Scholar
- Nelson JC, Jatlow PI, Quinlan DM, Bowers MB (1982 b) Desipramine plasma concentration and antidepressant response. Arch Gen Psychiatry 39: 1419–1422Google Scholar